4/2
08:10 am
mlys
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $30.00 price target on the stock.
Medium
Report
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $30.00 price target on the stock.
3/28
07:50 am
mlys
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "outperform" rating re-affirmed by analysts at Lifesci Capital.
Low
Report
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "outperform" rating re-affirmed by analysts at Lifesci Capital.
3/22
10:59 am
mlys
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/21
07:17 am
mlys
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/21
07:00 am
mlys
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Medium
Report
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
3/18
07:26 am
mlys
Mineralys Therapeutics: A Story To Keep An Eye On [Seeking Alpha]
Low
Report
Mineralys Therapeutics: A Story To Keep An Eye On [Seeking Alpha]
3/13
04:05 pm
mlys
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024
Low
Report
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024
2/9
10:21 am
mlys
Mineralys: 2nd Half 2024 Hypertension Data Readout [Seeking Alpha]
Low
Report
Mineralys: 2nd Half 2024 Hypertension Data Readout [Seeking Alpha]
2/8
08:00 am
mlys
Mineralys Therapeutics Announces $120 Million Private Placement Financing
Low
Report
Mineralys Therapeutics Announces $120 Million Private Placement Financing
1/29
04:05 pm
mlys
Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference
Low
Report
Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference